Section 1 of 6
Terms and abbreviations
1 evidence topic · 0 sources
| Abbreviation | Term |
|---|---|
| 5-HT3 | 5-hydroxytryptamine type 3 receptor |
| ADR | Adverse drug reaction |
| AHFS | American Hospital Formulary Service |
| ATC | Anatomical Therapeutic Chemical classification |
| ATS | American Thoracic Society |
| BS | Behavioral support |
| CAR | Continuous abstinence rate |
| CDC | Centers for Disease Control and Prevention |
| CI | Confidence interval |
| CMS | Centers for Medicare & Medicaid Services |
| CO | Carbon monoxide |
| COPD | Chronic obstructive pulmonary disease |
| CRL | Complete response letter |
| CVD | Cardiovascular disease |
| EML | Essential Medicines List |
| FDA | Food and Drug Administration |
| HBPB | Health benefit price benchmark |
| HR-QOL | Health-related quality of life |
| ICER | Institute for Clinical and Economic Review |
| MAIC | Matching-adjusted indirect comparison |
| NDA | New Drug Application |
| NICE | National Institute for Health and Care Excellence |
| NRT | Nicotine replacement therapy |
| OR | Odds ratio |
| QALY | Quality-adjusted life-year |
| QOL | Quality of life |
| RCT | Randomized controlled trial |
| RR | Risk ratio |
| SAE | Serious adverse event |
| SD | Standard deviation |
| SEPAR | Spanish Society of Pulmonology and Thoracic Surgery |
| SRNT | Society for Research on Nicotine and Tobacco |
| TB | Tuberculosis |
| TEAE | Treatment-emergent adverse event |
| TID | Three times daily |
| U.S. | United States |
| USPSTF | United States Preventive Services Task Force |
| WHO | World Health Organization |